APO Research
Talk to an analyst

APO RESEARCH · REPORT

Alcoholic Liver Diseases Treatment

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Alcoholic Liver Diseases Treatment Market Analysis and Forecast 2026-2032

19 December 2025197 pages

Choose your research edition.

Industry ResearchAlcoholic Liver Diseases Treatment Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Alcoholic Liver Diseases Treatment Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Alcoholic Liver Diseases Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alcoholic Liver Diseases Treatment Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Alcoholic Liver Diseases Treatment Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Alcoholic Liver Diseases Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Alcoholic Liver Diseases Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Alcoholic Liver Diseases Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Alcoholic Liver Diseases Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Alcoholic Liver Diseases Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Alcoholic Liver Diseases Treatment include Roche Holding, Upsher-Smith Laboratories, Bayer, GlaxoSmithKline, Pfizer, Novartis, Johnson & Johnson Services and Sanofi, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Alcoholic Liver Diseases Treatment, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Alcoholic Liver Diseases Treatment, also provides the revenue of main regions and countries. Of the upcoming market potential for Alcoholic Liver Diseases Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Alcoholic Liver Diseases Treatment revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Alcoholic Liver Diseases Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Alcoholic Liver Diseases Treatment revenue, projected growth trends, production technology, application and end-user industry.

Alcoholic Liver Diseases Treatment Segment by Company

Roche Holding

Upsher-Smith Laboratories

Bayer

GlaxoSmithKline

Pfizer

Novartis

Johnson & Johnson Services

Sanofi

Alcoholic Liver Diseases Treatment Segment by Type

Alcoholic Fatty Liver Disease

Alcoholic Liver Hepatitis

Others

Alcoholic Liver Diseases Treatment Segment by Application

Hospital Pharmacies

Drug Stores

Online Pharmacies

Retail Pharmacies

Others

Alcoholic Liver Diseases Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alcoholic Liver Diseases Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alcoholic Liver Diseases Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alcoholic Liver Diseases Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Alcoholic Liver Diseases Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Alcoholic Liver Diseases Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Alcoholic Liver Diseases Treatment revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Alcoholic Liver Diseases Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Alcoholic Fatty Liver Disease Major Player Table 3. Alcoholic Liver Hepatitis Major Player Table 4. Others Major Player Table 5. Global Alcoholic Liver Diseases Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Pharmacies Major Player Table 7. Drug Stores Major Player Table 8. Online Pharmacies Major Player Table 9. Retail Pharmacies Major Player Table 10. Others Major Player Table 11. Alcoholic Liver Diseases Treatment Industry Trends Table 12. Alcoholic Liver Diseases Treatment Industry Drivers Table 13. Alcoholic Liver Diseases Treatment Industry Opportunities and Challenges Table 14. Alcoholic Liver Diseases Treatment Industry Restraints Table 15. Global Alcoholic Liver Diseases Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Alcoholic Liver Diseases Treatment Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Alcoholic Liver Diseases Treatment Market Share by Region (2021-2026) Table 18. Global Alcoholic Liver Diseases Treatment Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Alcoholic Liver Diseases Treatment Market Share by Region (2027-2032) Table 20. Global Alcoholic Liver Diseases Treatment Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Alcoholic Liver Diseases Treatment Revenue Market Share by Players (2021-2026) Table 22. Global Alcoholic Liver Diseases Treatment Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Alcoholic Liver Diseases Treatment Key Players Headquarters & Area Served Table 24. Global Alcoholic Liver Diseases Treatment Players, Product Type & Application Table 25. Global Alcoholic Liver Diseases Treatment Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Alcoholic Liver Diseases Treatment by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Alcoholic Liver Diseases Treatment Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Alcoholic Liver Diseases Treatment Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Alcoholic Liver Diseases Treatment Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Alcoholic Liver Diseases Treatment Revenue Market Share by Type (2021-2026) Table 32. Global Alcoholic Liver Diseases Treatment Revenue Market Share by Type (2027-2032) Table 33. Global Alcoholic Liver Diseases Treatment Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Alcoholic Liver Diseases Treatment Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Alcoholic Liver Diseases Treatment Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Alcoholic Liver Diseases Treatment Revenue Market Share by Application (2021-2026) Table 37. Global Alcoholic Liver Diseases Treatment Revenue Market Share by Application (2027-2032) Table 38. Roche Holding Company Information Table 39. Roche Holding Business Overview Table 40. Roche Holding Alcoholic Liver Diseases Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Roche Holding Alcoholic Liver Diseases Treatment Product Portfolio Table 42. Roche Holding Recent Development Table 43. Upsher-Smith Laboratories Company Information Table 44. Upsher-Smith Laboratories Business Overview Table 45. Upsher-Smith Laboratories Alcoholic Liver Diseases Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Upsher-Smith Laboratories Alcoholic Liver Diseases Treatment Product Portfolio Table 47. Upsher-Smith Laboratories Recent Development Table 48. Bayer Company Information Table 49. Bayer Business Overview Table 50. Bayer Alcoholic Liver Diseases Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Bayer Alcoholic Liver Diseases Treatment Product Portfolio Table 52. Bayer Recent Development Table 53. GlaxoSmithKline Company Information Table 54. GlaxoSmithKline Business Overview Table 55. GlaxoSmithKline Alcoholic Liver Diseases Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. GlaxoSmithKline Alcoholic Liver Diseases Treatment Product Portfolio Table 57. GlaxoSmithKline Recent Development Table 58. Pfizer Company Information Table 59. Pfizer Business Overview Table 60. Pfizer Alcoholic Liver Diseases Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Pfizer Alcoholic Liver Diseases Treatment Product Portfolio Table 62. Pfizer Recent Development Table 63. Novartis Company Information Table 64. Novartis Business Overview Table 65. Novartis Alcoholic Liver Diseases Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Novartis Alcoholic Liver Diseases Treatment Product Portfolio Table 67. Novartis Recent Development Table 68. Johnson & Johnson Services Company Information Table 69. Johnson & Johnson Services Business Overview Table 70. Johnson & Johnson Services Alcoholic Liver Diseases Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Johnson & Johnson Services Alcoholic Liver Diseases Treatment Product Portfolio Table 72. Johnson & Johnson Services Recent Development Table 73. Sanofi Company Information Table 74. Sanofi Business Overview Table 75. Sanofi Alcoholic Liver Diseases Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Sanofi Alcoholic Liver Diseases Treatment Product Portfolio Table 77. Sanofi Recent Development Table 78. North America Alcoholic Liver Diseases Treatment Revenue by Type (2021-2026) & (US$ Million) Table 79. North America Alcoholic Liver Diseases Treatment Revenue by Type (2027-2032) & (US$ Million) Table 80. North America Alcoholic Liver Diseases Treatment Revenue by Application (2021-2026) & (US$ Million) Table 81. North America Alcoholic Liver Diseases Treatment Revenue by Application (2027-2032) & (US$ Million) Table 82. North America Alcoholic Liver Diseases Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 83. North America Alcoholic Liver Diseases Treatment Revenue by Country (2021-2026) & (US$ Million) Table 84. North America Alcoholic Liver Diseases Treatment Revenue by Country (US$ Million) & (2027-2032) Table 85. Europe Alcoholic Liver Diseases Treatment Revenue by Type (2021-2026) & (US$ Million) Table 86. Europe Alcoholic Liver Diseases Treatment Revenue by Type (2027-2032) & (US$ Million) Table 87. Europe Alcoholic Liver Diseases Treatment Revenue by Application (2021-2026) & (US$ Million) Table 88. Europe Alcoholic Liver Diseases Treatment Revenue by Application (2027-2032) & (US$ Million) Table 89. Europe Alcoholic Liver Diseases Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. Europe Alcoholic Liver Diseases Treatment Revenue by Country (2021-2026) & (US$ Million) Table 91. Europe Alcoholic Liver Diseases Treatment Revenue by Country (US$ Million) & (2027-2032) Table 92. China Alcoholic Liver Diseases Treatment Revenue by Type (2021-2026) & (US$ Million) Table 93. China Alcoholic Liver Diseases Treatment Revenue by Type (2027-2032) & (US$ Million) Table 94. China Alcoholic Liver Diseases Treatment Revenue by Application (2021-2026) & (US$ Million) Table 95. China Alcoholic Liver Diseases Treatment Revenue by Application (2027-2032) & (US$ Million) Table 96. Asia Alcoholic Liver Diseases Treatment Revenue by Type (2021-2026) & (US$ Million) Table 97. Asia Alcoholic Liver Diseases Treatment Revenue by Type (2027-2032) & (US$ Million) Table 98. Asia Alcoholic Liver Diseases Treatment Revenue by Application (2021-2026) & (US$ Million) Table 99. Asia Alcoholic Liver Diseases Treatment Revenue by Application (2027-2032) & (US$ Million) Table 100. Asia Alcoholic Liver Diseases Treatment Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 101. Asia Alcoholic Liver Diseases Treatment Revenue by Region (US$ Million) & (2021-2026) Table 102. Asia Alcoholic Liver Diseases Treatment Revenue by Region (US$ Million) & (2027-2032) Table 103. SAMEA Alcoholic Liver Diseases Treatment Revenue by Type (2021-2026) & (US$ Million) Table 104. SAMEA Alcoholic Liver Diseases Treatment Revenue by Type (2027-2032) & (US$ Million) Table 105. SAMEA Alcoholic Liver Diseases Treatment Revenue by Application (2021-2026) & (US$ Million) Table 106. SAMEA Alcoholic Liver Diseases Treatment Revenue by Application (2027-2032) & (US$ Million) Table 107. SAMEA Alcoholic Liver Diseases Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. SAMEA Alcoholic Liver Diseases Treatment Revenue by Country (2021-2026) & (US$ Million) Table 109. SAMEA Alcoholic Liver Diseases Treatment Revenue by Country (US$ Million) & (2027-2032) Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. Alcoholic Liver Diseases Treatment Image Figure 2. Global Alcoholic Liver Diseases Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alcoholic Liver Diseases Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 4. Alcoholic Fatty Liver Disease Image Figure 5. Alcoholic Liver Hepatitis Image Figure 6. Others Image Figure 7. Global Alcoholic Liver Diseases Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Alcoholic Liver Diseases Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Pharmacies Image Figure 10. Drug Stores Image Figure 11. Online Pharmacies Image Figure 12. Retail Pharmacies Image Figure 13. Others Image Figure 14. Global Alcoholic Liver Diseases Treatment Market Size (US$ Million) & (2021-2032) Figure 15. Global Alcoholic Liver Diseases Treatment Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Alcoholic Liver Diseases Treatment Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Alcoholic Liver Diseases Treatment Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Alcoholic Liver Diseases Treatment Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Alcoholic Liver Diseases Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Alcoholic Liver Diseases Treatment Revenue Market Share by Type (2021-2032) Figure 22. Global Alcoholic Liver Diseases Treatment Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Alcoholic Liver Diseases Treatment Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Alcoholic Liver Diseases Treatment Revenue Market Share by Application (2021-2032) Figure 25. North America Alcoholic Liver Diseases Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Alcoholic Liver Diseases Treatment Revenue Share by Type (2021-2032) Figure 27. North America Alcoholic Liver Diseases Treatment Revenue Share by Application (2021-2032) Figure 28. North America Alcoholic Liver Diseases Treatment Revenue Share by Country (2021-2032) Figure 29. United States Alcoholic Liver Diseases Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Alcoholic Liver Diseases Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Alcoholic Liver Diseases Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Alcoholic Liver Diseases Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Alcoholic Liver Diseases Treatment Revenue Share by Type (2021-2032) Figure 34. Europe Alcoholic Liver Diseases Treatment Revenue Share by Application (2021-2032) Figure 35. Europe Alcoholic Liver Diseases Treatment Revenue Share by Country (2021-2032) Figure 36. Germany Alcoholic Liver Diseases Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Alcoholic Liver Diseases Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Alcoholic Liver Diseases Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Alcoholic Liver Diseases Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Alcoholic Liver Diseases Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Alcoholic Liver Diseases Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Alcoholic Liver Diseases Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Alcoholic Liver Diseases Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Alcoholic Liver Diseases Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Alcoholic Liver Diseases Treatment Revenue Share by Type (2021-2032) Figure 46. China Alcoholic Liver Diseases Treatment Revenue Share by Application (2021-2032) Figure 47. Asia Alcoholic Liver Diseases Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Alcoholic Liver Diseases Treatment Revenue Share by Type (2021-2032) Figure 49. Asia Alcoholic Liver Diseases Treatment Revenue Share by Application (2021-2032) Figure 50. Asia Alcoholic Liver Diseases Treatment Revenue Share by Region (2021-2032) Figure 51. Japan Alcoholic Liver Diseases Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Alcoholic Liver Diseases Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Alcoholic Liver Diseases Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Alcoholic Liver Diseases Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Alcoholic Liver Diseases Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Alcoholic Liver Diseases Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Alcoholic Liver Diseases Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Alcoholic Liver Diseases Treatment Revenue Share by Type (2021-2032) Figure 59. SAMEA Alcoholic Liver Diseases Treatment Revenue Share by Application (2021-2032) Figure 60. SAMEA Alcoholic Liver Diseases Treatment Revenue Share by Country (2021-2032) Figure 61. Brazil Alcoholic Liver Diseases Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Alcoholic Liver Diseases Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Alcoholic Liver Diseases Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Alcoholic Liver Diseases Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Alcoholic Liver Diseases Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Alcoholic Liver Diseases Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Alcoholic Liver Diseases Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Alcoholic Liver Diseases Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Alcoholic Liver Diseases Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Alcoholic Liver Diseases Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Alcoholic Liver Diseases Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Alcoholic Fatty Liver Disease
  • Alcoholic Liver Hepatitis
  • Others
Applications
  • Hospital Pharmacies
  • Drug Stores
  • Online Pharmacies
  • Retail Pharmacies
  • Others
Companies covered
  • Roche Holding
  • Upsher-Smith Laboratories
  • Bayer
  • GlaxoSmithKline
  • Pfizer
  • Novartis
  • Johnson & Johnson Services
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Alcoholic Liver Diseases Treatment Market by Type
  3. 1.2.1 Global Alcoholic Liver Diseases Treatment Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Alcoholic Fatty Liver Disease
  5. 1.2.3 Alcoholic Liver Hepatitis
  6. 1.2.4 Others
  7. 1.3 Alcoholic Liver Diseases Treatment Market by Application
  8. 1.3.1 Global Alcoholic Liver Diseases Treatment Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital Pharmacies
  10. 1.3.3 Drug Stores
  11. 1.3.4 Online Pharmacies
  12. 1.3.5 Retail Pharmacies
  13. 1.3.6 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Alcoholic Liver Diseases Treatment Market Dynamics
  1. 2.1 Alcoholic Liver Diseases Treatment Industry Trends
  2. 2.2 Alcoholic Liver Diseases Treatment Industry Drivers
  3. 2.3 Alcoholic Liver Diseases Treatment Industry Opportunities and Challenges
  4. 2.4 Alcoholic Liver Diseases Treatment Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Alcoholic Liver Diseases Treatment Market Perspective (2021-2032)
  2. 3.2 Global Alcoholic Liver Diseases Treatment Growth Trends by Region
  3. 3.2.1 Global Alcoholic Liver Diseases Treatment Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Alcoholic Liver Diseases Treatment Market Size by Region (2021-2026)
  5. 3.2.3 Global Alcoholic Liver Diseases Treatment Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Alcoholic Liver Diseases Treatment Revenue by Players
  2. 4.1.1 Global Alcoholic Liver Diseases Treatment Revenue by Players (2021-2026)
  3. 4.1.2 Global Alcoholic Liver Diseases Treatment Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Alcoholic Liver Diseases Treatment Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Alcoholic Liver Diseases Treatment Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Alcoholic Liver Diseases Treatment Key Players Headquarters & Area Served
  7. 4.4 Global Alcoholic Liver Diseases Treatment Players, Product Type & Application
  8. 4.5 Global Alcoholic Liver Diseases Treatment Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Alcoholic Liver Diseases Treatment Market CR5 and HHI
  11. 4.6.3 2025 Alcoholic Liver Diseases Treatment Tier 1, Tier 2, and Tier 3
5 Alcoholic Liver Diseases Treatment Market Size by Type
  1. 5.1 Global Alcoholic Liver Diseases Treatment Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Alcoholic Liver Diseases Treatment Revenue by Type (2021-2032)
  3. 5.3 Global Alcoholic Liver Diseases Treatment Revenue Market Share by Type (2021-2032)
6 Alcoholic Liver Diseases Treatment Market Size by Application
  1. 6.1 Global Alcoholic Liver Diseases Treatment Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Alcoholic Liver Diseases Treatment Revenue by Application (2021-2032)
  3. 6.3 Global Alcoholic Liver Diseases Treatment Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Roche Holding
  2. 7.1.1 Roche Holding Company Information
  3. 7.1.2 Roche Holding Business Overview
  4. 7.1.3 Roche Holding Alcoholic Liver Diseases Treatment Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Roche Holding Alcoholic Liver Diseases Treatment Product Portfolio
  6. 7.1.5 Roche Holding Recent Developments
  7. 7.2 Upsher-Smith Laboratories
  8. 7.2.1 Upsher-Smith Laboratories Company Information
  9. 7.2.2 Upsher-Smith Laboratories Business Overview
  10. 7.2.3 Upsher-Smith Laboratories Alcoholic Liver Diseases Treatment Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Upsher-Smith Laboratories Alcoholic Liver Diseases Treatment Product Portfolio
  12. 7.2.5 Upsher-Smith Laboratories Recent Developments
  13. 7.3 Bayer
  14. 7.3.1 Bayer Company Information
  15. 7.3.2 Bayer Business Overview
  16. 7.3.3 Bayer Alcoholic Liver Diseases Treatment Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Bayer Alcoholic Liver Diseases Treatment Product Portfolio
  18. 7.3.5 Bayer Recent Developments
  19. 7.4 GlaxoSmithKline
  20. 7.4.1 GlaxoSmithKline Company Information
  21. 7.4.2 GlaxoSmithKline Business Overview
  22. 7.4.3 GlaxoSmithKline Alcoholic Liver Diseases Treatment Revenue and Gross Margin (2021-2026)
  23. 7.4.4 GlaxoSmithKline Alcoholic Liver Diseases Treatment Product Portfolio
  24. 7.4.5 GlaxoSmithKline Recent Developments
  25. 7.5 Pfizer
  26. 7.5.1 Pfizer Company Information
  27. 7.5.2 Pfizer Business Overview
  28. 7.5.3 Pfizer Alcoholic Liver Diseases Treatment Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Pfizer Alcoholic Liver Diseases Treatment Product Portfolio
  30. 7.5.5 Pfizer Recent Developments
  31. 7.6 Novartis
  32. 7.6.1 Novartis Company Information
  33. 7.6.2 Novartis Business Overview
  34. 7.6.3 Novartis Alcoholic Liver Diseases Treatment Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Novartis Alcoholic Liver Diseases Treatment Product Portfolio
  36. 7.6.5 Novartis Recent Developments
  37. 7.7 Johnson & Johnson Services
  38. 7.7.1 Johnson & Johnson Services Company Information
  39. 7.7.2 Johnson & Johnson Services Business Overview
  40. 7.7.3 Johnson & Johnson Services Alcoholic Liver Diseases Treatment Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Johnson & Johnson Services Alcoholic Liver Diseases Treatment Product Portfolio
  42. 7.7.5 Johnson & Johnson Services Recent Developments
  43. 7.8 Sanofi
  44. 7.8.1 Sanofi Company Information
  45. 7.8.2 Sanofi Business Overview
  46. 7.8.3 Sanofi Alcoholic Liver Diseases Treatment Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Sanofi Alcoholic Liver Diseases Treatment Product Portfolio
  48. 7.8.5 Sanofi Recent Developments
8 North America
  1. 8.1 North America Alcoholic Liver Diseases Treatment Revenue (2021-2032)
  2. 8.2 North America Alcoholic Liver Diseases Treatment Revenue by Type (2021-2032)
  3. 8.2.1 North America Alcoholic Liver Diseases Treatment Revenue by Type (2021-2026)
  4. 8.2.2 North America Alcoholic Liver Diseases Treatment Revenue by Type (2027-2032)
  5. 8.3 North America Alcoholic Liver Diseases Treatment Revenue Share by Type (2021-2032)
  6. 8.4 North America Alcoholic Liver Diseases Treatment Revenue by Application (2021-2032)
  7. 8.4.1 North America Alcoholic Liver Diseases Treatment Revenue by Application (2021-2026)
  8. 8.4.2 North America Alcoholic Liver Diseases Treatment Revenue by Application (2027-2032)
  9. 8.5 North America Alcoholic Liver Diseases Treatment Revenue Share by Application (2021-2032)
  10. 8.6 North America Alcoholic Liver Diseases Treatment Revenue by Country
  11. 8.6.1 North America Alcoholic Liver Diseases Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Alcoholic Liver Diseases Treatment Revenue by Country (2021-2026)
  13. 8.6.3 North America Alcoholic Liver Diseases Treatment Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Alcoholic Liver Diseases Treatment Revenue (2021-2032)
  2. 9.2 Europe Alcoholic Liver Diseases Treatment Revenue by Type (2021-2032)
  3. 9.2.1 Europe Alcoholic Liver Diseases Treatment Revenue by Type (2021-2026)
  4. 9.2.2 Europe Alcoholic Liver Diseases Treatment Revenue by Type (2027-2032)
  5. 9.3 Europe Alcoholic Liver Diseases Treatment Revenue Share by Type (2021-2032)
  6. 9.4 Europe Alcoholic Liver Diseases Treatment Revenue by Application (2021-2032)
  7. 9.4.1 Europe Alcoholic Liver Diseases Treatment Revenue by Application (2021-2026)
  8. 9.4.2 Europe Alcoholic Liver Diseases Treatment Revenue by Application (2027-2032)
  9. 9.5 Europe Alcoholic Liver Diseases Treatment Revenue Share by Application (2021-2032)
  10. 9.6 Europe Alcoholic Liver Diseases Treatment Revenue by Country
  11. 9.6.1 Europe Alcoholic Liver Diseases Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Alcoholic Liver Diseases Treatment Revenue by Country (2021-2026)
  13. 9.6.3 Europe Alcoholic Liver Diseases Treatment Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Alcoholic Liver Diseases Treatment Revenue (2021-2032)
  2. 10.2 China Alcoholic Liver Diseases Treatment Revenue by Type (2021-2032)
  3. 10.2.1 China Alcoholic Liver Diseases Treatment Revenue by Type (2021-2026)
  4. 10.2.2 China Alcoholic Liver Diseases Treatment Revenue by Type (2027-2032)
  5. 10.3 China Alcoholic Liver Diseases Treatment Revenue Share by Type (2021-2032)
  6. 10.4 China Alcoholic Liver Diseases Treatment Revenue by Application (2021-2032)
  7. 10.4.1 China Alcoholic Liver Diseases Treatment Revenue by Application (2021-2026)
  8. 10.4.2 China Alcoholic Liver Diseases Treatment Revenue by Application (2027-2032)
  9. 10.5 China Alcoholic Liver Diseases Treatment Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Alcoholic Liver Diseases Treatment Revenue (2021-2032)
  2. 11.2 Asia Alcoholic Liver Diseases Treatment Revenue by Type (2021-2032)
  3. 11.2.1 Asia Alcoholic Liver Diseases Treatment Revenue by Type (2021-2026)
  4. 11.2.2 Asia Alcoholic Liver Diseases Treatment Revenue by Type (2027-2032)
  5. 11.3 Asia Alcoholic Liver Diseases Treatment Revenue Share by Type (2021-2032)
  6. 11.4 Asia Alcoholic Liver Diseases Treatment Revenue by Application (2021-2032)
  7. 11.4.1 Asia Alcoholic Liver Diseases Treatment Revenue by Application (2021-2026)
  8. 11.4.2 Asia Alcoholic Liver Diseases Treatment Revenue by Application (2027-2032)
  9. 11.5 Asia Alcoholic Liver Diseases Treatment Revenue Share by Application (2021-2032)
  10. 11.6 Asia Alcoholic Liver Diseases Treatment Revenue by Country
  11. 11.6.1 Asia Alcoholic Liver Diseases Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Alcoholic Liver Diseases Treatment Revenue by Country (2021-2026)
  13. 11.6.3 Asia Alcoholic Liver Diseases Treatment Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Alcoholic Liver Diseases Treatment Revenue (2021-2032)
  2. 12.2 SAMEA Alcoholic Liver Diseases Treatment Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Alcoholic Liver Diseases Treatment Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Alcoholic Liver Diseases Treatment Revenue by Type (2027-2032)
  5. 12.3 SAMEA Alcoholic Liver Diseases Treatment Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Alcoholic Liver Diseases Treatment Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Alcoholic Liver Diseases Treatment Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Alcoholic Liver Diseases Treatment Revenue by Application (2027-2032)
  9. 12.5 SAMEA Alcoholic Liver Diseases Treatment Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Alcoholic Liver Diseases Treatment Revenue by Country
  11. 12.6.1 SAMEA Alcoholic Liver Diseases Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Alcoholic Liver Diseases Treatment Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Alcoholic Liver Diseases Treatment Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst